Bridgefront Capital LLC acquired a new position in CVS Health Co. (NYSE:CVS – Get Rating) during the third quarter, HoldingsChannel reports. The fund acquired 2,662 shares of the pharmacy operator’s stock, valued at approximately $254,000.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in CVS Health by 1.5% in the third quarter. Vanguard Group Inc. now owns 115,934,841 shares of the pharmacy operator’s stock worth $11,056,706,000 after purchasing an additional 1,726,512 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of CVS Health by 1.2% during the first quarter. Charles Schwab Investment Management Inc. now owns 11,699,284 shares of the pharmacy operator’s stock valued at $1,184,085,000 after acquiring an additional 134,457 shares during the period. Legal & General Group Plc lifted its stake in shares of CVS Health by 2.2% during the second quarter. Legal & General Group Plc now owns 10,321,160 shares of the pharmacy operator’s stock valued at $956,359,000 after acquiring an additional 220,516 shares during the period. Nordea Investment Management AB lifted its stake in shares of CVS Health by 38.6% during the second quarter. Nordea Investment Management AB now owns 9,680,490 shares of the pharmacy operator’s stock valued at $899,511,000 after acquiring an additional 2,697,382 shares during the period. Finally, Boston Partners lifted its stake in shares of CVS Health by 15.5% during the third quarter. Boston Partners now owns 8,034,788 shares of the pharmacy operator’s stock valued at $766,750,000 after acquiring an additional 1,077,638 shares during the period. Institutional investors and hedge funds own 77.29% of the company’s stock.
CVS Health Stock Up 0.6 %
NYSE:CVS opened at $75.83 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.67 and a current ratio of 0.94. The company has a market cap of $97.37 billion, a PE ratio of 24.30, a PEG ratio of 1.18 and a beta of 0.65. CVS Health Co. has a 52-week low of $74.52 and a 52-week high of $109.69. The stock has a 50-day simple moving average of $85.75 and a 200 day simple moving average of $93.22.
CVS Health Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, May 1st. Investors of record on Friday, April 21st will be given a dividend of $0.605 per share. This represents a $2.42 annualized dividend and a yield of 3.19%. CVS Health’s dividend payout ratio (DPR) is presently 77.56%.
Analyst Ratings Changes
Several equities analysts have recently issued reports on the company. TheStreet raised CVS Health from a “c+” rating to a “b” rating in a research note on Friday, November 25th. Wells Fargo & Company lowered their price target on CVS Health from $106.00 to $101.00 and set an “equal weight” rating for the company in a report on Tuesday, January 3rd. Morgan Stanley increased their price target on CVS Health from $119.00 to $120.00 and gave the stock an “overweight” rating in a report on Friday, January 13th. Raymond James lowered their price target on CVS Health from $115.00 to $110.00 and set an “outperform” rating for the company in a report on Thursday, February 9th. Finally, Credit Suisse Group increased their price target on CVS Health from $117.00 to $125.00 and gave the stock an “outperform” rating in a report on Monday, November 21st. Three investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $119.65.
CVS Health Profile
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate and Other. The Pharmacy Services segment focuses on the pharmacy benefit management solutions.
- Get a free copy of the StockNews.com research report on CVS Health (CVS)
- Don’t Miss Out: $2 Trillion Could be Headed to the Banking Sector
- A Weakening Economy Suggests Caution Before Buying Five Below
- Williams-Sonoma: Time To Buy At Rock-Bottom Prices
- Why DraftKings Could Keep Outperforming in 2023
- Charles Schwab And The Safest 30% You Can Make This Year
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Get Rating).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.